Related references
Note: Only part of the references are listed.Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes Clinical article
Jason P. Sheehan et al.
JOURNAL OF NEUROSURGERY (2011)
Defining the edge of the envelope: patient selection in treating complex sellar-based neoplasms via transsphenoidal versus open craniotomy Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Efficacy and complications of neurosurgical treatment of acromegaly
Anna Krzentowska-Korek et al.
PITUITARY (2011)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2010)
Radiation treatment strategies for acromegaly
Nathan C. Rowland et al.
NEUROSURGICAL FOCUS (2010)
Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas
Gabriel Zada et al.
NEUROSURGICAL FOCUS (2010)
The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas
Christopher J. Stapleton et al.
NEUROSURGICAL FOCUS (2010)
Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations
Gabriel Zada et al.
NEUROSURGICAL FOCUS (2010)
A systematic analysis of disease control in acromegaly treated with radiosurgery
Isaac Yang et al.
NEUROSURGICAL FOCUS (2010)
Outcome of Stereotactic Radiotherapy for Patients with Uncontrolled Acromegaly
Syed Ali Imran et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2009)
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
S. J. C. M. M. Neggers et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases
Heng Wan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Radiotherapy and radiosurgery in acromegaly
Frederic Castinetti et al.
PITUITARY (2009)
Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas
Chul Bum Cho et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2009)
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
I. M. Holdaway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: Results from a 15-year experience
Bruce E. Pollock et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma
Marco Losa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mortality in acromegaly: A meta analysis
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Gamma knife radiosurgery for acromegaly: Outcomes after failed transsphenoidal surgery
Jay Jagannathan et al.
NEUROSURGERY (2008)
Transcranial surgery for pituitary adenomas
Michael Buchfelder et al.
PITUITARY (2008)
Current diagnosis of acromegaly
Rocio A. Cordero et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Surgery for acromegaly: Evolution of the techniques and outcomes
Edward R. Laws
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Gamma knife stereotactic radiosurgery for acromegaly
Einar Osland Vik-Mo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission
Bruce E. Pollock et al.
JOURNAL OF NEUROSURGERY (2007)
Linear accelerator radiosurgery for pituitary macroadenomas - A 7-year follow-up study
Juergen Voges et al.
CANCER (2006)
Visual field preservation after multisession CyberKnife radiosurgery for perioptic lesions
John R. Adler et al.
NEUROSURGERY (2006)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant
AL Barkan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Outcome of gamma knife radiosurgery in 82 patients with acromegaly:: Correlation with initial hypersecretion
F Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure?
T Kobayashi et al.
JOURNAL OF NEUROSURGERY (2005)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly
A Bourdelot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Assessment of long-term remission of acromegaly following surgery
MD Krieger et al.
JOURNAL OF NEUROSURGERY (2003)
Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions
G Zada et al.
JOURNAL OF NEUROSURGERY (2003)
Radiotherapy and stereotactic radiosurgery for pituitary tumors
Z Petrovich et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2003)
Failure of radiotherapy in acromegaly
R Cozzi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Surgical management of GH-secreting pituitary adenomas: An outcome study using modern remission criteria
J Kreutzer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Gamma knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas
N Zhang et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2000)
Octreotide may act as a radioprotective agent in acromegaly
AM Landolt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
